Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cosmeceuticals.

D Kligman1

  • 1S.K.I.N., Incorporated, Conshohocken, Pennsylvania 19428, USA.

Dermatologic Clinics
|November 4, 2000
PubMed
Summary
This summary is machine-generated.

Evaluating new cosmeceuticals like kinetin requires assessing skin penetration, biochemical mechanisms, and clinical trial evidence. Currently, furfuryladenine lacks published data on efficacy and mechanism in human skin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trauma rounds.

Canadian Medical Association journal·2010
Same author

Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited.

Journal of the American Academy of Dermatology·2000
Same author

Salicylic acid peels for the treatment of photoaging.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·1998
Same author

Molecular analysis of microtubule-associated protein-2 kinase cDNA from mouse and rat brain.

DNA and cell biology·1991
Same author

Nonscalp hair infection caused by Microsporum canis in patient with acquired immunodeficiency syndrome.

Journal of the American Academy of Dermatology·1991
Same author

Differential expression of an 80-kDa protein kinase C substrate in preneoplastic and neoplastic mouse JB6 cells.

Proceedings of the National Academy of Sciences of the United States of America·1989
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Dermatology and Cosmeceutical Science
  • Biochemistry and Molecular Biology
  • Clinical Research Methodology

Background:

  • The evaluation of new cosmeceutical ingredients, such as kinetin (a plant-derived nucleotide), presents challenges for dermatologists.
  • Topical nucleotide penetration of human skin is established, exemplified by 5-fluorouracil (5-FU) used for actinic keratoses.
  • However, the penetration of other nucleotides, like furfuryladenine, into photodamaged skin remains unclear.

Purpose of the Study:

  • To outline a framework for assessing the efficacy and safety of novel cosmeceutical products.
  • To critically examine the evidence supporting the use of kinetin as a case study.
  • To highlight the need for rigorous scientific validation of cosmeceutical claims.

Main Methods:

Related Experiment Videos

  • Assessing the potential for stratum corneum penetration of topical nucleotides.
  • Investigating plausible biochemical mechanisms of action for active ingredients.
  • Reviewing the availability of peer-reviewed, double-blinded, placebo-controlled clinical trials.

    • Main Results:

    • Topical 5-fluorouracil (5-FU) demonstrates skin penetration and a known mechanism of action.
    • The mechanism of action for furfuryladenine in human skin is currently unknown, though antioxidant activity is hypothesized.
    • No published peer-reviewed, double-blinded, placebo-controlled clinical trials substantiate the efficacy of furfuryladenine to date.

    Conclusions:

    • Rigorous scientific evidence, including clinical trials, is essential for validating cosmeceutical claims.
    • Further research is required to determine the physiological benefits and mechanisms of novel ingredients like furfuryladenine in human skin.
    • Many purported cosmeceutical agents may lack demonstrable physiological benefit without further validation.